Pablo G. Legorreta

CIK 1507678 · CEO, Chairman of the Board · last filed 2026-05-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$105.66M

Companies

3

Total Filings

24

Lifetime Open-Market Net

$19.59M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PROK Director 22,617,909 $1.64 $37.09M $0 5 2026-05-29
RPRX CEO, Chairman of the Board 1,249,534 $54.87 $68.56M $19.59M 17 2026-05-08
Epizyme, Inc. (EPZM) Delisted Director 9,166,667 $1.47 $13.48M $0 2 2020-06-02

Recent Filings · Page 2 of 3

24 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-03 PROK Grant (A) $0 EDGAR
2023-11-16 RPRX Mixed −90,809 $0 EDGAR
2023-07-03 PROK Grant (A) $0 EDGAR
2023-06-28 RPRX Buy (P) +130,000 $3.84M EDGAR
2023-06-13 RPRX Buy (P) +90,000 $2.96M EDGAR
2023-05-24 RPRX Buy (P) +150,000 $4.84M EDGAR
2023-05-17 RPRX Buy (P) +230,000 $7.68M EDGAR
2023-05-15 RPRX Gift (G) $0 EDGAR
2022-04-15 RPRX Mixed +110,139 $0 EDGAR
2022-04-15 RPRX Grant (A) $0 EDGAR
Showing 1120 of 24
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.